| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
2008
|
|
3 |
p. 207-207
|
artikel
|
| 2 |
Antiviral agents in Alzheimer’s disease: hope for the future?
|
Wozniak, Matthew A.
|
|
2010
|
|
3 |
p. 141-152
|
artikel
|
| 3 |
Antiviral agents in Alzheimer’s disease: hope for the future?
|
Wozniak, Matthew A.
|
|
2010
|
|
3 |
p. 141-152
|
artikel
|
| 4 |
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
|
Collongues, Nicolas
|
|
2016
|
|
3 |
p. 180-188
|
artikel
|
| 5 |
A pilot study on the benefit of cognitive rehabilitation in Parkinson’s disease
|
Adamski, Natalia
|
|
2016
|
|
3 |
p. 153-164
|
artikel
|
| 6 |
A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures
|
Chung, Steve S.
|
|
2015
|
|
3 |
p. 131-136
|
artikel
|
| 7 |
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series
|
Murray, Stacey
|
|
2016
|
|
3 |
p. 189-197
|
artikel
|
| 8 |
Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry
|
Tsivgoulis, Georgios
|
|
2014
|
|
3 |
p. 155-161
|
artikel
|
| 9 |
Diagnosis and treatment of impulse control disorders in patients with movement disorders
|
Mestre, Tiago A.
|
|
2013
|
|
3 |
p. 175-188
|
artikel
|
| 10 |
Diagnostic workup and management of patients with suspected Niemann-Pick type C disease
|
Papandreou, Apostolos
|
|
2016
|
|
3 |
p. 216-229
|
artikel
|
| 11 |
Efficacy and safety of rufinamide in pediatric epilepsy
|
Hsieh, David T.
|
|
2013
|
|
3 |
p. 189-198
|
artikel
|
| 12 |
Endovascular thrombectomy with or without systemic thrombolysis?
|
Tsivgoulis, Georgios
|
|
2017
|
|
3 |
p. 151-160
|
artikel
|
| 13 |
Erratum
|
|
|
2012
|
|
3 |
p. 181-181
|
artikel
|
| 14 |
Erratum
|
|
|
2010
|
|
3 |
p. 197-198
|
artikel
|
| 15 |
Erratum
|
|
|
2010
|
|
3 |
p. 197-198
|
artikel
|
| 16 |
Erythropoietin: still on the neuroprotection road
|
Subirós, Nelvys
|
|
2012
|
|
3 |
p. 161-173
|
artikel
|
| 17 |
Ethical challenges in paediatric clinical trials in multiple sclerosis
|
Tenembaum, Silvia N.
|
|
2012
|
|
3 |
p. 139-146
|
artikel
|
| 18 |
Exercise in the management of persons with multiple sclerosis
|
Giesser, Barbara S.
|
|
2015
|
|
3 |
p. 123-130
|
artikel
|
| 19 |
Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome
|
Purcarin, Gabriela
|
|
2014
|
|
3 |
p. 169-176
|
artikel
|
| 20 |
Fixed-dose sumatriptan/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free/no adverse events
|
Landy, Stephen
|
|
2009
|
|
3 |
p. 135-141
|
artikel
|
| 21 |
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
|
Mayer, Marie Cathrin
|
|
2012
|
|
3 |
p. 147-159
|
artikel
|
| 22 |
Hypothalamic deep brain stimulation in the treatment of chronic cluster headache
|
Leone, Massimo
|
|
2010
|
|
3 |
p. 187-195
|
artikel
|
| 23 |
Hypothalamic deep brain stimulation in the treatment of chronic cluster headache
|
Leone, Massimo
|
|
2010
|
|
3 |
p. 187-195
|
artikel
|
| 24 |
Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke
|
Yi, Xingyang
|
|
2017
|
|
3 |
p. 161-170
|
artikel
|
| 25 |
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
|
Virhammar, Johan
|
|
2017
|
|
3 |
p. 171-187
|
artikel
|
| 26 |
Management of vestibular migraine
|
Bisdorff, Alexandre R.
|
|
2011
|
|
3 |
p. 183-191
|
artikel
|
| 27 |
Management of women with multiple sclerosis through pregnancy and after childbirth
|
Coyle, Patricia K.
|
|
2016
|
|
3 |
p. 198-210
|
artikel
|
| 28 |
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis
|
Phillips, J. Theodore
|
|
2008
|
|
3 |
p. 151-153
|
artikel
|
| 29 |
Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
|
Racke, Michael K.
|
|
2008
|
|
3 |
p. 155-156
|
artikel
|
| 30 |
Neurostimulation for chronic cluster headache
|
Wolter, Tilman
|
|
2012
|
|
3 |
p. 175-180
|
artikel
|
| 31 |
Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting
|
Holtkamp, Martin
|
|
2011
|
|
3 |
p. 169-181
|
artikel
|
| 32 |
Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience
|
Holle-Lee, Dagny
|
|
2016
|
|
3 |
p. 230-234
|
artikel
|
| 33 |
Optical coherence tomography as a potential readout in clinical trials
|
Greenberg, Benjamin M.
|
|
2010
|
|
3 |
p. 153-160
|
artikel
|
| 34 |
Optical coherence tomography as a potential readout in clinical trials
|
Greenberg, Benjamin M.
|
|
2010
|
|
3 |
p. 153-160
|
artikel
|
| 35 |
Para-dichlorobenzene toxicity – a review of potential neurotoxic manifestations
|
Dubey, Divyanshu
|
|
2014
|
|
3 |
p. 177-187
|
artikel
|
| 36 |
Progress in enzyme replacement therapy in glycogen storage disease type II
|
Angelini, Corrado
|
|
2009
|
|
3 |
p. 143-153
|
artikel
|
| 37 |
Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy
|
Liew, Wendy K. M.
|
|
2013
|
|
3 |
p. 147-160
|
artikel
|
| 38 |
Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency
|
Chen, Shih-Pin
|
|
2010
|
|
3 |
p. 161-171
|
artikel
|
| 39 |
Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency
|
Chen, Shih-Pin
|
|
2010
|
|
3 |
p. 161-171
|
artikel
|
| 40 |
Review: Comparing drug treatments in epilepsy
|
Chadwick, David
|
|
2009
|
|
3 |
p. 181-187
|
artikel
|
| 41 |
Review: Drug and nondrug treatment in tension-type headache
|
Bendtsen, Lars
|
|
2009
|
|
3 |
p. 155-161
|
artikel
|
| 42 |
Review: Escalating immunotherapy of multiple sclerosis
|
Rieckmann, Peter
|
|
2008
|
|
3 |
p. 181-192
|
artikel
|
| 43 |
Review: Future perspectives for brain pharmacotherapies: implications of drug transport processes at the blood—brain barrier
|
Hermann, Dirk M.
|
|
2008
|
|
3 |
p. 167-179
|
artikel
|
| 44 |
Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis
|
Bartels, Claudia
|
|
2008
|
|
3 |
p. 193-206
|
artikel
|
| 45 |
Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies
|
Dalakas, Marinos C.
|
|
2008
|
|
3 |
p. 157-166
|
artikel
|
| 46 |
Review: Therapy for Alzheimer's disease: how effective are current treatments?
|
Lanctôt, Krista L.
|
|
2009
|
|
3 |
p. 163-180
|
artikel
|
| 47 |
Sphenopalatine ganglion stimulation for the treatment of cluster headache
|
Láinez, Miguel J. A.
|
|
2014
|
|
3 |
p. 162-168
|
artikel
|
| 48 |
Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy
|
Yoon, Min-Suk
|
|
2011
|
|
3 |
p. 193-200
|
artikel
|
| 49 |
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice
|
de Sa, João Carlos Correia
|
|
2011
|
|
3 |
p. 139-168
|
artikel
|
| 50 |
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
|
Lehmann-Horn, Klaus
|
|
2013
|
|
3 |
p. 161-173
|
artikel
|
| 51 |
The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience
|
Steinhoff, Bernhard J.
|
|
2015
|
|
3 |
p. 137-147
|
artikel
|
| 52 |
The pathogenesis of multifocal motor neuropathy and an update on current management options
|
Léger, Jean-Marc
|
|
2015
|
|
3 |
p. 109-122
|
artikel
|
| 53 |
Therapeutic developments in spinal muscular atrophy
|
Sproule, Douglas M.
|
|
2010
|
|
3 |
p. 173-185
|
artikel
|
| 54 |
Therapeutic developments in spinal muscular atrophy
|
Sproule, Douglas M.
|
|
2010
|
|
3 |
p. 173-185
|
artikel
|
| 55 |
Timing of cigarette smoking as a risk factor for multiple sclerosis
|
Salzer, Jonatan
|
|
2013
|
|
3 |
p. 205-205
|
artikel
|
| 56 |
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report
|
Stroet, Anke
|
|
2013
|
|
3 |
p. 199-203
|
artikel
|
| 57 |
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry
|
Stangel, Martin
|
|
2016
|
|
3 |
p. 165-179
|
artikel
|
| 58 |
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature
|
Dubey, Divyanshu
|
|
2016
|
|
3 |
p. 211-215
|
artikel
|
Tijdschrift beschrijving